Non-Alcoholic Fatty Liver Disease research hub
9 indexed studies · 4 currently recruiting
- recruiting
Integrated Diagnostics for Early Diagnosis of Liver Disease
This study aims to find better ways to spot liver disease early, especially scarring (fibrosis). Researchers are looking at blood tests, gut bacteria, and other information from patients in local clinics. They hope to create a new, improved test that's more accurate than current methods.
United Kingdom - active not recruiting
Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes
This study checks for other health issues often linked with Type 2 diabetes and pre-diabetes, like problems with your heart, liver, or sleep. It's testing a new, more thorough health check-up to find these problems earlier.
United Kingdom - active not recruitingPHASE2
Phase 2b Study of GSK4532990 in Adults With NASH
This study is testing a new medicine, GSK4532990, for people with a serious liver condition called Non-Alcoholic Steatohepatitis (NASH). We want to see if this medicine can improve liver damage and inflammation compared to a dummy medicine.
United States · Argentina · Australia - recruiting
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
This study is gathering information about a liver condition called Non-Alcoholic Fatty Liver Disease (NAFLD) in children across Europe. Doctors and scientists are working together to understand it better, find new treatments, and see how it develops over time in young people.
Netherlands · United Kingdom - active not recruiting
Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study
This study uses smartwatches to understand how movement affects health for people with conditions like heart disease or diabetes. Researchers hope to find ways to predict health changes and improve wellbeing programmes using the information from the watches.
United Kingdom - active not recruiting
MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)
This study looks at how non-alcoholic fatty liver disease (NAFLD) gets worse. We use special scans and tests to understand changes in the body and how a substance called L-carnitine might help. This could lead to better ways to find and treat liver problems early.
United Kingdom - active not recruitingPHASE2
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
This study is looking into a new medicine called efinopegdutide for a liver condition called MASH. We want to see if it can help reduce liver fat, swelling, and scarring in people with MASH and mild scarring. It also checks how safe the medicine is.
United States · Australia · Canada - recruiting
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
This study aims to understand Non-Alcoholic Fatty Liver Disease (NAFLD) better. We're looking at different body samples to see how immune systems, gut bacteria, and metabolism are involved in NAFLD, especially in people having weight-loss surgery.
United Kingdom - recruitingPHASE4
Fibrosis Lessens After Metabolic Surgery
This study looks at how well weight-loss surgery compares to new medicines for treating liver disease. It focuses on a condition called MASH, which is linked to being overweight and can cause liver damage.
United States · Brazil · Canada